The following video is from Friday's Motley Fool Money weekly roundtable discussion with host Chris Hill, as well as analysts Ron Gross, Charly Travers, and Joe Magyer.
In this segment, Google's (NASDAQ: GOOGL ) annual Zeitgeist report included the top 10 "most Googled stocks of 2012." Charly shares why Arena Pharmaceuticals (NASDAQ: ARNA ) breakthrough drug and stock performance has investors searching for shares.
When it comes to do-or-die business, the biotech industry takes the cake. Arena Pharmaceuticals is one recent success story in the industry after gaining FDA approval for its innovative obesity drug. While the future looks bright for Arena, there are still plenty of obstacles ahead. In our brand new premium research report on Arena Pharmaceuticals, we walk investors through the must-know opportunities and threats facing the company. Since key news can develop quickly, we're also including a full year of updates for those who sign up. Click here now to learn more.